FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/05/2025
Voltar para busca
Dado oficial do USPTO
ELASMOGEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
19/04/2023
Data de registro
19/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/11/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
MICKLEBURGH, LINDA BOHANNON
Unidade examinadora
L60
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "ELASMOGEN" with an irregular circular shape replacing the letter "O".
Titulares e representantes
Titulares
Elasmogen Ltd
Representantes
Charlene M. Krogh Dorsey & Whitney LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for treatment of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseases and eye diseases and disorders; biological preparations for treatment of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseases and eye diseases and disorders; diagnostic preparations agentssubstances for medical purposes; anti-angiogenesis preparations; anti-cancer preparations; anti-inflammatory preparations; pharmaceutical and biochemical preparations for the treatment or prevention of cancerinfectious diseasephysiological disordershormonal disordersinherited diseasesingle gene disordersrespiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsimmuno-deficienciesorgan damagecell proliferationperipheral neurological disordersgenitourinary disordersmusculoskeletal disordersblood disorders; diagnostic reagents for medical use; DNAantibodies and proteins for medical diagnosis purposes; DNA and antibodies and proteins that stimulate cells for medical use; DNAantibodies and proteins for therapeutic use for treatment of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseases and eye diseases and disorders; diagnostic preparations for medical purposes; reagents for medical use
Classe 42
Medical and pharmacological research services; scientific and technological servicesnamely scientific researchanalysis and testing in the field of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseaseseye diseases and disordersintracellular delivery of pharmaceuticals and therapeutics; scientific research for medical purposes in the field of cancerinflammatory diseasesauto-inflammatory diseasesautoimmune diseaseseye diseases and disordersintracellular delivery of pharmaceuticals and therapeutics; pharmaceutical research and drug development services; pharmaceutical testing; research and development in the biotechnology field; research and development services in the field of antibodies; biotechnology research services; scientific research in the nature of conducting clinical trials for others; biological researchclinical research and medical research; providing scientific information about the results of clinical trials for pharmaceutical products; research services in the field of diagnostic preparations; scientific laboratory services; custom design and development of biochemical assays; scientific and medical research laboratory services; research and development of new products for others; scientific research and analysis in the field of drug discovery; new product development in the field of pharmaceuticals for others; scientific advisory servicesmedical advisory services related to pharmaceutical development and testing; scientific research consultancy in the field of cancer researchinflammatory disease researchauto-inflammatory disease researchautoimmune disease researcheye disease and disorder researchintracellular delivery research of pharmaceuticals and therapeutics; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; consulting services for others in the field of designplanningimplementation and project management of scientific research and clinical trials; providing scientific research information; technical advisory services relating to scientific and clinical research; provision of technical and scientific information and consultancy in relation to the aforesaid services
Classe 44
Medical services; medical advisory services relating to the treatmentrelief and prevention of cancerinfectious diseasephysiological disordershormonal disordersinherited diseasesingle gene disordersrespiratory diseasesgastro-intestinal disorderscirculatory disordersdermatological conditionsimmuno-deficienciesorgan damagecell proliferationperipheral neurological disordersgenitourinary disordersmusculoskeletal disordersblood disorders; preparation and provision of medical reports to patients and medical professionals; preparation and provision of medical information in the form of reports on pharmaceuticalsadvanced therapy medicinal productstherapeutic antibodies to patients and medical professionals; consultancyadvice and information in the field of healthcarepharmaceuticals and advanced therapy medicinal products
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/04/2025
FIMP
FINAL DISPOSITION PROCESSED
16/04/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
19/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2024
PUBO
PUBLISHED FOR OPPOSITION
03/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/07/2024
RFNT
REFUSAL PROCESSED BY IB
19/02/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/02/2024
RFRR
REFUSAL PROCESSED BY MPU
01/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/01/2024
CNRT
NON-FINAL ACTION WRITTEN
17/01/2024
DOCK
ASSIGNED TO EXAMINER
17/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
03/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ELASMOGEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.